Goodfellow Gems #199

+Practice
In print

Goodfellow Gems #199

Bruce Arroll

Bruce Arroll

Heart
[Image: Kenny Eliason on Unsplash]

“Spironolactone may reduce atrial fibrillation incidence”

A systematic review of 10 trials of mineralocorticoid receptor antagonists (MRAs; eg, spironolactone) found a 23% reduction in the risk of atrial fibr
References

pubmed.ncbi.nlm.nih.gov/37269781 (Am J Cardiol 2023;199:85–91).